Date of death -estimated.Date of event - estimated.The unique device identifier (udi) is unknown because the part and lot numbers were not provided.Implant date - estimated.The devices were not returned for evaluation.A review of the lot history records could not be conducted because the part and lot numbers were not provided.The reported patient effect of death is listed in the xience v everolimus eluting coronary stent systems instructions for use (ifu) as a known patient effect of coronary procedures.A conclusive cause for the reported deaths and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.The adverse patient events reported in the article and in are filed under a different medwatch mfr number.Literature title : percutaneous coronary intervention vs coronary artery bypass grafting in patients with left main coronary artery stenosis: a systematic review and meta-analysis.
|
This is filed for the deaths.It was reported through a research article that xience stents may be related to death, myocardial infarction, target lesion revascularization, stroke, stent occlusion, and re-hospitalization.Specific patient information is unknown.Additional information can be found in the article "percutaneous coronary intervention vs coronary artery bypass grafting in patients with left main coronary artery stenosis: a systematic review and meta-analysis".Please see article for additional information.
|